These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18657962)

  • 1. Immunosuppression in renal transplantation: some aspects for the modern era.
    Chadban S; Morris R; Hirsch HH; Bunnapradist S; Arns W; Budde K
    Transplant Rev (Orlando); 2008 Oct; 22(4):241-51. PubMed ID: 18657962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?
    Nashan B
    Transplant Rev (Orlando); 2009 Jan; 23(1):47-52. PubMed ID: 19027616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunosuppressors].
    Sánchez-Fructuoso AI
    Nefrologia; 2008; 28 Suppl 5():21-5. PubMed ID: 18847416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
    Bemelman FJ; de Maar EF; Press RR; van Kan HJ; ten Berge IJ; Homan van der Heide JJ; de Fijter HW
    Transplantation; 2009 Aug; 88(3):421-8. PubMed ID: 19667948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale and criteria of eligibility for calcineurin inhibitor interruption following kidney transplantation.
    Danger R; Giral M; Soulillou JP; Brouard S
    Curr Opin Organ Transplant; 2008 Dec; 13(6):609-13. PubMed ID: 19060551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The mechanisms of chronic kidney damage in renal transplant and their possible reversibility].
    Schena FP; Maiorano A; Rossini M
    G Ital Nefrol; 2008; 25 Suppl 44():S11-4. PubMed ID: 19048580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppressive strategies to improve outcomes of kidney transplantation.
    Tang IY; Meier-Kriesche HU; Kaplan B
    Semin Nephrol; 2007 Jul; 27(4):377-92. PubMed ID: 17616271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic allograft dysfunction: can we use mammalian target of rapamycin inhibitors to replace calcineurin inhibitors to preserve graft function?
    Wali RK; Weir MR
    Curr Opin Organ Transplant; 2008 Dec; 13(6):614-21. PubMed ID: 19060552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of immunosuppressive regimens on graft survival and secondary outcomes after kidney transplantation.
    Opelz G; Döhler B;
    Transplantation; 2009 Mar; 87(6):795-802. PubMed ID: 19300179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance immunosuppression regimens: conversion, minimization, withdrawal, and avoidance.
    Yang H
    Am J Kidney Dis; 2006 Apr; 47(4 Suppl 2):S37-51. PubMed ID: 16567240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for immunosuppression in lung transplantation.
    Hopkins PM; McNeil K
    Curr Opin Organ Transplant; 2008 Oct; 13(5):477-83. PubMed ID: 19060529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppression for heart transplantation: where are we now?
    Kobashigawa JA; Patel JK
    Nat Clin Pract Cardiovasc Med; 2006 Apr; 3(4):203-12. PubMed ID: 16568129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunosuppressive agents in pediatric renal transplantation].
    Ismaili K; Abramowicz D; Adams B; Godefroid N; Lolin K; Schurmans T; Hall M; Janssen F
    Rev Med Brux; 2005; 26(6):505-12. PubMed ID: 16454154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of immunosuppression on the development of BK virus nephropathy-- does it matter?
    Beimler J; Sommerer C; Zeier M
    Nephrol Dial Transplant; 2007 Sep; 22 Suppl 8():viii66-viii71. PubMed ID: 17890267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FK778 ameliorates post-transplant expression of fibrogenic growth factors and development of chronic rejection changes in rat kidney allografts.
    Rintala JM; Savikko J; Rintala SE; von Willebrand E
    Nephrol Dial Transplant; 2008 Nov; 23(11):3446-55. PubMed ID: 18558624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immune monitoring of kidney transplant recipients: can markers predictive of over-immunosuppression be identified?].
    Saas P; Courivaud C; Bamoulid J; Garnache-Ottou F; Seilles E; Ducloux D
    Ann Pharm Fr; 2008 Mar; 66(2):115-21. PubMed ID: 18570910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcineurin nephrotoxicity.
    Williams D; Haragsim L
    Adv Chronic Kidney Dis; 2006 Jan; 13(1):47-55. PubMed ID: 16412970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming barriers to long-term graft survival.
    Kaplan B
    Am J Kidney Dis; 2006 Apr; 47(4 Suppl 2):S52-64. PubMed ID: 16567241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.